Shannon T. Kelley Insider Trades
General CounselGeneral Counsel at Madrigal Pharmaceuticals, Inc.. 1 significant open-market trade reported on SEC Form 4 in the last 180 days.
$0
Bought
$342K
Sold
0 / 1
Buys / Sells
1
Companies
Companies
- MDGLGeneral Counsel
Madrigal Pharmaceuticals, Inc.
1 sell, $342K · 1 alert in our log
Reported Trades
Open-market transactions only (code P and S), outside any 10b5-1 plan, dated by the day the filing reached EDGAR. Each row links to the filing.
| Filed | Company | Trade | Value |
|---|---|---|---|
| Aug 20, 2026 | MDGLGeneral Counsel | sell5.5% of stake | $342K |
Other Insiders at These Companies
Everyone else who reported a significant open-market trade at the same company in the last 180 days. Several insiders buying at once is cluster buying.
- Baker Bros. Advisors LPDirector at MDGL1 buy, $35.0M
- 667, L.P.Director at MDGL1 buy, $35.0M
- Baker Bros. Advisors (gp) LLCDirector at MDGL1 buy, $35.0M
- Baker Brothers Life Sciences LPDirector at MDGL1 buy, $35.0M
- Felix BakerDirector at MDGL1 buy, $35.0M
- Julian BakerDirector at MDGL1 buy, $35.0M
How to Read This Page
These are the trades an insider chose to make with their own money, not grants, option exercises or tax withholding. A purchase is the stronger signal (why buys carry more information than sales), and an insider who buys is locked out of selling for six months by the short-swing rule. The window here is 180 days; the full filing history lives on EDGAR. This record has fewer than 2 trades under $500K, so it is not yet listed on the hub.
Get this insider's next buy when it files
InsiderWatch reads every Form 4 as it reaches EDGAR, keeps the open-market buys that matter, and sends them by email and Telegram.
Try free for 7 daysEvery alert we send is logged with its timestamp and source.